Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL

K-Number: K950399 · 1995-02-22

ApplicantBionostics, Inc.
Decision Date1995-02-22
Product CodeJJY
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL is the device name listed in this FDA 510(k) record. The listed applicant is Bionostics, Inc.. It received FDA 510(k) clearance on 1995-02-22 under 510(k) number K950399. The device is classified under product code JJY. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL?

RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL is a medical device that received FDA 510(k) clearance on 1995-02-22. The listed applicant is Bionostics, Inc.. The 510(k) number is K950399.

When did RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL receive FDA 510(k) clearance?

RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL received FDA 510(k) clearance on 1995-02-22, under 510(k) number K950399.

Who is the listed applicant for RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL?

The FDA 510(k) record lists Bionostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL?

The FDA product code for RNA MEDICAL'S EQUIL PLUS WITH GLUCOSE CONTROL is JJY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Bionostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K131136GLUCOSE METER-CHECK SOLUTION FOR TAIDOCK123851GLUCOSE METER-CHECK SOLUTION FOR ROCHE ACCU-CHEKK123966GLUCOSE METER-CHECK SOLUTION FOR BAYERK113764GLUCOSE METER-CHECK SOLUTION FOR INFOPIAK112352GLUCOSE METER-CHECK CONTROL FOR NIPRO TRUERESULTK112356GLUCOSE METER-CHECK CONTROL SOLUTION FOR AGAMATRIX WAVESENSE

View all 49 devices →

Related Devices (Code: JJY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K162530Multichem IA PlusTechno-Path ManufacturingK163629Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.K163015Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2; Liquichek Tumor Marker Control-Level 3; Liquichek Tumor Marker Control- Trilevel MiniPakBio-Rad LaboratoriesK153712VK-3 Verification Kit, VK-4 Verification Kit, VK-R5 Verification Kit, VK-R7 Verification Kit, VK-Crea Verification KitRadiometer America, Inc.K132227LIQUICHEK IMMUNOASSAY PREMIUM CONTROL-TRILEVEL, LIQUICHEK IMMUNOASSAY PREMIUM CONTROL-LEVEL I, LIQUICHEK IMMUNOASSAYBio-Rad LaboratoriesK132156RANDOX CSF CONTROLS LEVELS 2 AND 3Randox Laboratories, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑